Michael Silbermann
Executive Director
Middle East Cancer Consortium
Israel
Biography
Professor Michael Silbermann (D.M.D.; Ph.D., and certified specialist in oral and maxillo facial surgery; Chief Resident at Boston City Hospital in Oral and Maxillo-Facial Surgery, Ph.D. at Tufts University Medical School (Boston, MA), Post-doc at USC in Los Angeles, CA and the NIH, Bethesda, MD) was head of the laboratory for musculoskeletal research at the Faculty of Medicine in the Technion. He has gained international reputation through multinational research projects related to skeletal development, metabolism and senescence, funded by international research agencies (Israel National Council for Research and Development, Ministry of Science; Chief Scientist Office in the Ministries of Health, and Commerce and Industry; NIH, USAID, and BSF in the United States; BMBF, GBF and GSF in Germany). Large financial support was obtained also from industries. He has been awarded research fellowship grants by the American Association of Dental Research, The Fogarty Foundation (Bethesda, MD), EMBO, Max Planck Society, and Japan Society for the Promotion of Sciences. He served as the Chairman of the Department of Anatomy and Cell Biology, Faculty of Medicine; Dean of the Faculty of Medicine, Technion; Chief Scientist, Ministry of Health; Chairman of the Board of Governors, the United States-Israel Binational Science Foundation; Member of the Committee for the Promotion of Infrastructure in Biomedical Research, Ministry of Science, State of Israel; Member of the Foulkes Foundation (United Kingdom) Committee for Doctoral Fellowships; The Isreal Academy of Sciences and Humanities; Member of the National Committee for Ethics in Science and Intellectual Property, Israel; Executive Director, the Middle East Cancer Consortium since its establishment in 1996; First representative of the State of Israel in the European Commission in the Program Committee of Bio-Medical Research; EU, Brussels; Chairman, National Committee for Examining Academic Specialty Training in Health, Social and Education Professionals, The Council for Higher Education, State of Israel; Excellence in Biomaterials and Tissue Engineering, The Finnish Academy of Sciences, Helsinki, Finland. Serves as Editor of J. Palliative Care & Medicine, and Editor-in-Chief of Palliative Medicine and Hospice.
Research Interest
His research interests include end of life, Surviviorship research,Quality of life (Qol),And the delivery of palliative care